DATA PERTAINING TO THE PAIN REFUGEE CRISIS

Twitter data final to hhs

Thomas F. Kline MD, PhD                                                    JATH                                                                    Carolyn M. Concia, NP

David John Williams                          EDUCATIONAL CONSORTIUM, LLC **                 Jaime James Sanchez

                                                                                        6409 Pernod Way

                                                                                                 Raleigh, North Carolina 27613

                                                                                                              919-561-0144

                                                                         

                                                                                Pain Refugee Statistics

                                    DATA PERTAINING TO THE PAIN REFUGEE CRISIS

April 1, 2019

A crisis ten times the size of opioid epidemic has begun to occur and is worsening daily.  I am observing it with horror from my position as an independent chronic and rare disease specialist with more than 40 years experience and no ties to anything but my responsibilities to care for all of the patient, especially when suffering.

I have never seen a health care crisis develop of this magnitude without anyone seemingly knowing it is occurring.  I could never have imagined this happening within the United States of America.

The opioid crisis has nothing to do with office pain patients with one of many permanent, painful disease disorders.  Cardiac disease needs cardiac medication.  Painful disease needs pain medication.

On March 15, 2016 the CDC issued the “Guideline for Prescription of Opioids for Chronic pain” which started the cascade of disenfranchisement of potentially millions of legitimate innocent patients with very nasty painful rare diseases.

The “Guideline” has grossly interfered with the doctor-patient relationship by implying primary care doctors needed education in safe (read reduced) prescribing, as over prescribing by doctors was responsible for the opioid epidemic.  This is a terrible accusation and needs substantial establishment of validity before a federal agency would issue such serious statement.  To this date they have not provided the needed validity.  But regardless, the “Guideline” provided the accelerant for the wildfire that is actually getting worse each day as access to medical care for painful diseases is closing rapidly.

There are 10 million patients with painful diseases (Dr. Volkow)  such as:  Ehlers-Danlos, CRPS or Complex Regional Pain Syndrome, Adhesive Arachnoiditis from spinal injections, failed back surgery, Trigeminal Neuralgia, Chiari Syndrome of the brain being displaced, advanced inoperable multi-joint destructive disease, Central Pain Syndrome with Chronic Brain Inflammation (old title “fibromyalgia), pain syndromes following trauma, especially in Veterans with war wounds, Interstitial Cystitis, and about 25 more rare disorders.  None of these can be treated with Tylenol or with CDC “alternatives”.

No one has shown prescribing “too much” is the real reason behind the “overdose deaths” in street heroin addicts, a fact the CDC failed to disclose.  Of the 40,000 overdose deaths reported by the CDC 39,500 died from heroin addiction without medical care. None of the studies looked closely at Cause of Death, just association. Association may or may not be causal, which possibly could drop prescription overdose death rate in general population to near 0. Of 64 million people prescribed opiates 500 or less possibly died of OD.

In fact “opioid exposure” is like “demon exposure.”  It actually has nothing to do with genetically driven opiate addiction or Chemical Receptor Disease.  If it were true the $600 billion spent on substance control (CRS) would have worked by now.  The reason it has not worked and will not work is the pathophysiology of type 2 addiction or classical Heroin addiction is different from other addictions where exposure to substance is a factor.

Mass hysteria or Fear of Addiction Phobia has exploded pre-existing prejudices into a destructive mythology harming a large number of innocent bystanders – the pain refugees. This national fear is as bad or worse than previous fears of being possessed by the devil leading to hangings in 1692,  fears in the 1950’s communists in every walk of life,  fear in the 1980’s with “crack cocaine dope fiends” raiding communities in the 1980s, and the fear of catching HIV on every toilet seat.  

This mass hysteria is worse now, actual deaths are occurring from suicides to relieve pain caused by forcibly stopping effective, safe medicines.  Potentially millions of lives are being ruined people unable to function without proper treatment of the painful disease.  No one is counting these. No one really is seeking the truth.

CDC may say they didn’t really mean it that way, but they published a “Guideline” that looked much like a regulation when only the FDA has congressional authority to publish concerning any prescription drug.  I was and is taken with the zealousness of a real regulation – which it is not. Internally the “Guideline” does not discuss when to use opiates with the implication that they should never be used.

The “Guideline” is written as corrective actions for the wrongs of primary care doctors.  The doctors responded by stopping the opioid prescriptions as they did after federal narcotic police arrests in beginning in 1915 after the Harrison Act, a federal attempt to control pain medicines deemed by the police to be dangerous causing “highs’.  In the last three years two thirds of primary doctors have done the same thing – “send ‘em to pain management,” whatever that is.

CDC and their opioid avoidance consultants have tried to walk back the idea of forced tapering  in a futile and illogical attempt to reduce the heroin street deaths, a ludicrous, dangerous notion that cutting based on flawed thinking that back on substance exposure is what causes heroin addiction.  This is not true. It is doesn’t even make sense.  How can taking frightening sobbing people off medicines they know have saved their functional lives stop overdoses in street addicts.  There is something very wrong with logical thinking.  It sounds more polemic and it sounds policy based on fear of medicines for pain.

Whether the CDC regulations are valid is a moot point.  As a result of demonizing 50 centuries of the opiate pain medicine, and as a result of blaming primary care doctors, and as a result attempts to remove opiate pain medicine as the drug of choice, we have nearly annihilated the use of “God’s Medicine” in the words of Sir William Osler, father of Internal Medicine.

The following descriptive data is taken from my twitter following.  There are approximately 25,000 people in this group of chronic painful disease patients.  The data is sidewalk interview type data with those choosing to respond providing the data.  Each question had between 200 and 500 respondents.  This information is offered a beginning point.  We need to further define this serious and widespread injury to potentially millions of people.

The CDC was tasked by its Scientific Advisors to follow up to see if any unintended consequences were occurring. It has been three years.  No reports have been seen.  The unintended consequences of destruction of lives and suicide deaths remain unknown but until proven otherwise the estimate remains in the millions of American citizens, mainly women. These are people who did nothing to deserve being caught in the crossfire of opioid zealotry.  

Some facts:

1.  Ten million people in the US need to take daily opiate medication, of the 25.3 million with daily pain lasting longer than three months with 15 million already trying alternatives.

2.  Four different surveys, including my own Twitter poll indicate 60-70% of the ten million are being actively tapered off opiate pain regimens without medical reason.

3.  When asked why the doctors were tapering for no reason patients reported they were told it was due to the CDC and DEA.  (“I cannot lose my license over this, you will need to deal with your pain”)

4.  Fifty percent of the ten million with legitimate long term, incurable painful diseases are completely taken off medicines that should never have been taken away lacking a medical reason.

5.  Two thirds of primary care doctors have quit prescribing opiate pain medicine in the last three years

6.  Picking up the slack, pain specialists now bursting at the seams to help those denied access for their disease, are being raided by federal and state drug squads for “having too many patients”, and “prescribing more than any other doctor” – a crime I never heard of.  Punished for helping out.

7.  This data to follow is informal and should have been obtained by the CDC.  But, the obvious is not always an illusion>  Reading the stories of 28,000 pain patients makes me believe these these probes are more than likely portray the truth.

These statistics are from those patients who have been tapered down or off their pain medicines:

–After tapering 89% had more pain, 11% less pain or no change 302 12-27

–Sleep was worse in 92%  (sleep deprivation is a new secondary disease from tapering)

–70% were forced to taper against their will with their strong protestations and tears ignored

–Dependence or having withdrawl is pretty much the same as addiction. 18% yes 2-4 82% no

— 2/3 of patients require more than 90mg Mme per day (CDC never checked if 90mg would work)

      (FDA, the rulemaking agency for opiates has not recommended tapering and by law and regulations  has no maximum amount or dose)

–Those doing “fine” after the tapering  15%

–negative impact on parenting – 78%

–negative impact on sexuality – 88%  (78% stopped having sex altogether)

–negative impact on  social activities like PTA, church, civic activities:  57% stopped activities,  major reduction 36%, no change 3%

– -“big” problems with relationships – 92%

— weight gain 45%, weight loss 35%, no change 20%

–considered an addict for taking pain medicine- 50% said yes

–Flagged in computers as “drug seekers” – 43%

— agree or disagree with the statement made by opiate opposed doctors that long term opiate medicine is ineffective:  82% disagree

–Percentage of painful disease patients refused medication because they did not have cancer -69%

–Statement by CDC Director Thomas Frieden MD that “doctors are the cause of the opioid epidemic” – 82% disagreed

–Veterans: after two months off meds or tapered are you better for it? Yes better 13% worse 29% a lot worse 58% 112 1-17

–Antidepressant helped: quite a bit 9% maybe helped some 22% did not help 69%

Side effects of antidepressant: major 53% mild to moderatle 26% none 26%

–Do you know a vet: 12% no tapering 51% Stopped, 37% reduced 141 1-14

–Percentage receiving “adequate pain medicines”  17%

– suicide numbers – unknown.  CDC is reporting sharp rise in suicides especially in women.  About 70% of the population of chronic painful diseases are women, reflecting similar weighting in autoimmune disease.  CDC has not reported and data on why the increase in suicides.  It must be assumed to be related to pain so great as to make life  not a life until proved otherwise. One CDC person interviewed indicated the notion of medication tapering suicides said they were not studying this.  Google “medium suicides” for case reports.

–Problems filling their doctors’ prescriptions at the pharmacy -33%

–Major “life changes” – 68%

–Tapered off or down on pain medicines  but still doing “ok”    6%  94% worse

— Forced tapering without a say so-  76%

— tapering effects on employment- no change 3%, negative effect 36%, had to quit job 61%

–once tapering was found to increase pain and decrease functioning how many had their original doses restored- – 13%, 76% of practitioners refused to restore  to previous effective levels

— Percentage of “doctor shoppers” who are addicts – 40%, percentage who are pain patients -60%

— Percentage of patients currently looking for doctors but cannot find one— 65% (of ten million presumably)

CDC recommends using alternative, second line treatments first, not a standard medical practice I am familiar with..  Generally we physicians like to treat with the most effective first, back ups if the drug of choice fails.  As a result of the stampede to more expensive, higher risk and reduced effectiveness we asked several questions in each poll–

–Back surgery, was it “worth it”? – yes 23% , 77% no

–Neck surgery, was it worth it?  – 68% no, 32% yes

–Physical Therapy helped – 10%,  PT made it worse 43%

— Alternate medicines worked as well as the opiates:  5%  yes, 95% no

–Lyrica – effective in only 8%, noticeable side effects 72%

–Neurontin, side effects in more than half, worked in only 13% little or none 35% side effects bad 46% side effects minimal 6%

–Spinal Stimulators implanted by surgery, “was it worth it”? – no in 86% (40-50K dollars)

–ketamine infusions – effective in 50%  

–Morphine pumps “did it relieve pain”? – 50% yes, 50% no (30-50K dollars plus monthly fees, surgical risks)

–Injection treatments, “would you recommend to others with the same diseases?”  47% said no (high risk of addisonian adrenal suppression and adhesive arachnoiditis, a disastrous lifelong disease)

–Radiofrequency ablation, “was it worth doing?” – 79% said no, 21% said yes  (extremely painful and expensive procedure)

–of those without addiction how many felt euphoria when starting: 16%, euphoria later

–euphoria from gabepentin: heard of this? 24% yes 296 1-2

Most patients are referred to pain clinics.  The status of licensing requirements is unknown. People who no longer are treated for their pain by their regular doctors, traditionally the ones who treated pain prior to 2015, who now go to “Pain Clinics” are asked to respond on twitter polls.

Contracts, pill counts, urine-analyses were traditionally reserved for opiate addicts.  It is not clear why these methods are forced on the pain patients abandoned by their primary care practitioners.  They report the following:

–forced to sign addiction style pain contracts -80%  restricting what pharmacies to go to,  forced birth control, etc  one person committed suicide after an ER relief prescription was refused by the pharmacy due to restrictive pain control (google Medium Suicides)

–numbers reporting good care at the pain clinic- -25%, not so good in 25%, “terrible” care 50%

–Number of pain clinics not prescribing actual pain medication – 25-31%

–Number of pain clinics offering “injections only” – 41%

–Number of pain clinics refusing to prescribe pain medicines until patient agrees to injections first–34%

–Number of pain clinics prescribing pain medicine according to FDA guidelines- 18%

–Number of patients that were not sent to Pain clinics by their primary care and followed in the office for the pain treatment – 19%, with 63% were “referred out”

–50% have to pay $100-$300 for each pain clinic visit after insurance pays

–Forced to have addiction type urine tests  in spite of no one ever reported to addict already on pain medications with false positive and negative rates leading to discharge from pain clinic and labeling as drug seekers on EHR records damming the patient for ever in receiving pain medication for any reason.

–How many have problems getting your pain meds at pharmacies: at chain pharmcies 55% at independent 1% 115 sample of 15k 12-16-17

— repeating the poll in a different way: now many in general have had problems filling your prescriptions at pharmacies- 33% have had a problem 31% at chains 2% at independent pharmacies 225 sample from 15k 12-17-17

— “honestly now, pulling no punches do you believe over prescribing by doctors is contributing to overdose deaths Yes 18% No 82% 284 votes of 15k 12-22-17

–the CDC and PROP Believes long term medication continues to be taken after three months just to hold off withdrawal Agree 18% Disagree 82% 273 votes of 15k 12-20-17

–of you looking for new doctors to prescribe pain meds how many docs/np’s/pa’s have you contacted 1-10 34% more than 10: 9% eventually successful 15% still looking 42% 122 votes

–are you getting proper and adequate treatment for your painful disease? yes getting good treatment 21% No not getting adequate treatment for your painful disease 79% 175 votes 12-23-17

–Reactions by doctors and practitioners when telling you are going to be tapered against your will: neutral 41% vindictive 29% nice or sad 24% gleeful 6% 228 1-22

–How many of you have been denied pain medicine because you don’t have cancer 69% 251 votes

–Medical society with plan for board protection 23 votes 17% yes

In general painful disease patients are also reporting:

–34% take both benzodiazepines and opiate with no problems reported in  87%, problems in 13%

–Two percent report benzodiazepines work best to relieve pain, opiates work best 52% and the combination of benzodiazepines and opiates work best in 36%, with neither working in  10%

–Outcomes with opiate pain medicine:  89% reporting “good”

–Numbers of patients in the universe of twitter followers officially disabled from their painful diseases: 53%

–requiring more than 90mg MME for pain control: 63%

These twitter polls were conducted by JATH over the last two years.  Many of the polls were validated by other polls outside of JATH.  The polls cannot be dismissed by saying they were not properly done.  The obvious is not always an illusion.  Are these randomly stratified samplings – no.    This information is provided to issue an alert.

Opiate drugs have an addiction rate of 0.5% – a major side effect but which can be managed easily if caught early.  If each prescriber would merely ask their patients if they have ever had an opiate we would stop new deaths from opiate addiction.   With this simple question no more teenagers will die due to ignorance of the pathophysiology of opiate addiction and the different types.  There is no such thing as “addiction” or “drug abuse”, but there are types of addiction  which are very different and need to be treated differently just as we do with the two types of diabetes.  

If the answer to the critical question “ever had a pain killer before” is YES the person will never opiate addict.  If the answer is NO they will have < 1% change for genetically determined opiate addiction.  The prescriber needs to warn “no” patients to report back if they have other than a sedative effect from the narcotic especially if they “go on a magic carpet ride”   If they do,  they have opiate addiction disease, type 2.   They need not seek out heroin and die.  No new cases of addiction need to die.  Ninety percent of opiate addiction occurs in teenage years.  Why? – First exposure.   Opiate addiction differs from other forms of addiction as it is triggered by the hidden propensity for immediate addiction.  This is why the news stories report the addiction from the doctors prescription – first exposure, not “substance exposure”.  

Thus identified, the patients can be medically treated in the office. Opiate addiction is serious side effect, but it is not fatal like many serious side effects of other prescription drugs.  We need to ask more about the facts of the two types of addiction and why they are different.  We cannot apply one solution for both.  This is where the mistakes have been made, and money wasted for 100 years.   We need medical facts, pathophysiological facts before we subject millions of people to the withdrawal of medical treatment without rhyme or reason.   It is their choice to take the risks or not take the risks, not the government, not doctors cowed into harming their patients, not the drug police.

Of any new idea,  Einstein said that some things are easy to understand but hard to believe.  This is offered in that light.  I have seen it.  Heads are in the sand. A nationwide tragedy  is really happening on a scale no one could ever imagine.  

Thomas F. Kline MD, Ph.D

Chronic and Rare Disease Specialist

Raleigh, North Carolina

Web: thomasklinemd.com

Email: thomasklinemd@gmail.com    Intelligent discussions are welcome

**JATH Educational Consortium LLC is a Raleigh based research group providing unrestricted data to the medical community and the general public for policy making and improvement of medical care

Myth #6 Pain Refugees taken off opioid. Who are they? .. Thomas Kline MD

Myth #6 Pain Refugees taken off opioid. Who are they? .. Thomas Kline MD

MYTH #5 IS OVER PRESCRIBING A FEDERAL CRIME Thomas Kline MD

In 1915 thousands of doctors were arrested, and jailed when the federal drug police didn’t like doctors treating addicts. Narcotic police make up medical crimes. Arrests were reversed by Supreme Court in 1925 268 US 5, Court saying federal government had no place in state regulated medical issues. 104 years later – doctors are arrested for overprescribing a medical infraction without statutory basis.

Myth #4 Are Heroin Addicts Evil… Thomas Kline MD

or is it an irrational Fear of Addiction Phobia that makes us afraid when other addictions: alcohol, cocaine, amphetamines are more dangerous. He “takes drugs” dependent on which drug. Two classes of addiction are presented for the first time to begin to understand the horrible pain refugee crisis

Is this typical of how a national health insurance works ?

How the NHS won‘t give mother life extending cancer drug

https://stockdailydish.com/how-the-nhs-wont-give-mother-life-extending-cancer-drug/

How the NHS won‘t give Bonnie a cancer drug that will extend her life – yet spends millions on treatments that don‘t work

Bonnie Fox was denied a vital drug on cost grounds

Bonnie Fox is dying. In April 2015 she gave birth to Barnaby, her first child. Four months later her joy turned to horror when, after experiencing problems breastfeeding, she was diagnosed with advanced and incurable breast cancer.

That was 19 months ago. Since then Bonnie, 39, has been through six months of debilitating chemotherapy and is now on the twin ‘maintenance’ drugs, Herceptin and Perjeta.

For how long is anyone’s guess — ‘the longest I have heard is 12 years, but I have also heard of women for whom they’ve stopped working after a year’, says Bonnie, from Croydon, Surrey.

Juggling treatments and baby-care, Bonnie has returned two days a week to her demanding job as a project manager, and in June last year she married her partner and Barnaby’s father, Ash, the manager of a Waterstones book store.

Now she has one all-consuming ambition: to live long enough to be there for Barnaby’s first day at school.

Her best hope of that is an ‘end-of-life’ drug called Kadcyla, which ‘would buy me more time with my little boy . . . with Kadcyla I might even see him get to school, which, for me, would be a huge milestone to reach’.

But Bonnie can’t have Kadcyla. On December 29, the National Institute for Health and Care Excellence (NICE) announced that, at a cost of £90,000 for each of the 1,200 patients who, like Bonnie, could benefit from the drug, the price was ‘too high in relation to the benefits it gives for it to be recommended for routine commissioning in the NHS’.

‘Cheated once’ by fate, Bonnie says she now feels ‘cheated again: I was relying on that drug’.

Then she read the news that the NHS is paying silly money for other drugs which, with joined-up negotiating, it could be getting for far less.

As much as £380 million a year is being wasted by GPs alone because they’re paying over the odds for drugs that have had their prices hiked by pharmaceutical companies, according to Dr Andrew Hill, a senior research fellow in pharmacology at the University of Liverpool.

The fault, he says, lies with NHS England for failing to track and act over these price hikes.

And that’s just prescriptions in the community in England. Factor in hospitals and all prescribing in Scotland, Wales and Northern Ireland, says Dr Hill, and ‘I wouldn’t be surprised if we’re talking about a billion pounds here in overcharging’.

Dr Hill’s team analysed prices paid for 300 drugs from 2011 to 2015. The biggest price rise they found was the 2,340 per cent increase in the cost of the thyroid drug carbimazole, which cost the NHS an extra £29.8 million in 2015. The cost of the antidepressant drug nortriptyline went up 419 per cent in the same period, landing the NHS with an additional bill of £25.5 million.

‘You would think the NHS would be able to control this,’ Dr Hill told Good Health. ‘This is such an easy opportunity to save money.’

And when you consider the hopes of patients such as Bonnie, this waste is simply immoral.

‘I’m very pro the NHS, it’s been wonderful to me and my family, and I do appreciate it has so many conflicting demands,’ says Bonnie. ‘But when I hear about wastage like this, it is so frustrating.’

One of the many ironies of waste is that while some patients are being denied treatments the NHS can’t afford, others are getting care they don’t need.

As Professor Terence Stephenson, chairman of the Academy of Medical Royal Colleges, has put it: ‘One doctor’s waste is another patient’s . . . lack of treatment.’

The healthcare think tank, The King’s Fund, has highlighted 16 NICE guidelines about sticking to treatments that actually work which, if followed across the NHS, could save £1.9 million per 100,000 of population — in England alone that’s a saving in excess of £1 billion.

Some of the useless, wasteful treatments and procedures given to patients include X-rays for diagnosing lower back pain, and a plaster cast on small wrist fractures in children.

These ‘will heal just as quickly with a removable splint’, according to a report published last October by the Academy of Medical Royal Colleges. The academy published a list of 40 treatments and procedures ‘of little or no benefit to patients’, but costly to the NHS.

For example, it said, tap water ‘is just as good for cleaning cuts and grazes as saline solution’.

Sometimes these needless — and wasteful — treatments can do more harm than good. As reported in the Mail last month, 800,000 people in the UK have been on antidepressants for two years or more, with no clinical reason for taking them.

Similarly, an estimated 250,000 people have been on highly addictive tranquillisers for months or even years, despite clear official guidance that no one should take them for longer than four weeks.

Apart from the financial cost (the combined bill to the NHS of the over-prescription of antidepressants, tranquillisers and opioid painkillers may be £160 million every year) there is the human cost to the thousands left to struggle alone with dependency and withdrawal.

Chris Ham, chief executive of The King’s Fund, says that while evidence suggested the NHS was ‘one of the most efficient health systems in the world’, there is ‘still significant scope to improve productivity and reduce waste’.

With the NHS facing ‘huge financial pressures’ it was ‘essential to focus on getting the best possible value for patients from every pound spent . . . for example, through addressing the overuse of certain drugs and treatments or [ensuring] patients are seen faster and don’t need to stay in hospital for so long.’

More galling, perhaps, is the money wasted on the significant variation in executive pay and perks. Take John Adler, chief executive at University Hospitals of Leicester NHS Trust. From just over £245,000 in the financial year to 2015, his total salary and pension package almost doubled the following year to a whopping £485,000 — an astonishing increase of almost 98 per cent.

Yet the trust’s financial review for that year conceded, it had ‘not met all of our financial and performance duties for 2015/16’ and it recorded a deficit of £34.1 million.

What’s more, a Good Health investigation last month revealed Adler’s trust was one of the ten with the largest number of medication errors in NHS England — 2,449 in 2015, causing harm to patients in 185 cases.

In most cases, such errors were blamed by experts on unsafe staffing levels among nurses.

The trust says Adler gets the going rate for the job. Tell that to the chief executive at Leeds Teaching Hospitals NHS Trust, who has almost 3,000 more staff to manage than Adler’s 14,000, yet gets a more modest £272,000 pay-and-pension package.

It’s a similar story at Sheffield Teaching Hospitals NHS Foundation Trust, where the chief executive struggled by on £250,000 less than Mr Adler and has 2,000 more staff to manage.

Mr Adler’s not the only senior manager doing well. A survey of boardroom pay in the NHS last year found that 355 trust directors in England received average salary increases of 2.3 per cent — considerably more than the 1 per cent pay cap imposed on nurses since 2010.

A spokesman for NHS Improvement, the organisation that oversees trusts, said that while the NHS ‘needs strong and capable leaders to meet the challenges it faces’, when it comes to executive pay levels ‘we expect trusts to exercise restraint and we strongly discourage new appointments at the highest pay levels’.

Yet another form of waste that costs the patient and the NHS dear is infection rates. Infections cost money because of the extra surgery and care involved. Infection rates vary wildly, for no obvious good reason. And so do other costly things.

In September 2016, Public Health England identified 102 inexplicable ‘unwarranted variations’, many of which were costing the NHS money. For example, it found that for no obvious reason, the number of days patients being kept in hospital after fracturing a thigh bone ranged from ten to more than 30.

The longer stay, which simply isn’t necessary, increases the risk of contracting hospital infections and blocks beds badly needed by other patients.

And the NHS is in the grip of yet another hugely ambitious IT project, with hospitals poised to plough millions of pounds into new systems, converting hospitals, GPs and pharmacies to electronic records, online appointments and prescriptions to make the NHS paperless by 2020.

It’s as though the disastrous £10 billion National Programme for IT, introduced in 2002 with exactly the same ambitions and finally scrapped barely four years ago, never happened.

NEXT WEEK: How the NHS could save millions simply by saying sorry when things go wrong.

To all current pharmacists, student pharmacists, potential future pharmacists – RUN — FORREST —RUN

 

Durbin, Kennedy Urge DEA To Use Its New Authorities To Lower Opioid Quotas

Durbin, Kennedy Urge DEA To Use Its New Authorities To Lower Opioid Quotas

https://www.durbin.senate.gov/newsroom/press-releases/durbin-kennedy-urge-dea-to-use-its-new-authorities-to-lower-opioid-quotas

Letter Follows Recent Bipartisan Law And Amendment Yesterday Directing DEA To More Proactively Prevent Big Pharma’s Excessive Opioid Production

WASHINGTON – U.S. Senators Dick Durbin (D-IL) and John Kennedy (R-LA) today, in a letter to Drug Enforcement Administration (DEA) Acting Administrator Uttam Dhillon, called on DEA to use its new authorities—passed into law by Durbin and Kennedy last year—to prevent and limit opioid diversion by properly regulating the pharmaceutical industry and appropriately reducing opioid production quotas for 2020.  In its 2020 proposal, DEA explained it would only lower opioid production quotas based upon reported theft loss and seizures, an inadequate reflection of the abuse, overdose, and public health harms created by excessively high production levels that the DEA approves for drug manufacturers.  The Senators urged DEA to better comply with the 2018 law they passed and not to ignore important health information when setting new opioid production quotas.

“We fear that the explanation provided by DEA for ignoring the clear connection between the staggering volumes of painkillers approved for production and the current overdose epidemic signals that DEA is reverting to the short-sighted approach that precipitated this opioid crisis.  The statute is clear that DEA must exercise its quota authority to serve as a gatekeeper and weigh the public health impact of how many opioids it allows to be sold each year in the United States,” Durbin and Kennedy wrote.

Between 1993 and 2015, the DEA allowed production of oxycodone to increase 39-fold, hydrocodone to increase 12-fold, and fentanyl to increase 25-fold.  As a result, the number of opioid pain relievers dispensed in the United States skyrocketed. The increase in opioid-related overdose deaths has mirrored the dramatic rise in opioid prescribing, with more than 42,000 deaths in 2016.

In 2016, the pharmaceutical industry put 14 billion opioid doses on the market—enough for every adult to have a one-month supply.

Last year, after passage of Durbin and Kennedy’s Opioid Quota Reform Act of 2018, DEA was granted new authorities that enhanced its opioid quota-setting authority by improving transparency and enabling DEA to adjust quotas to prevent opioid diversion and abuse while ensuring an adequate supply for legitimate medical needs.  This is the first year DEA set quotas with the new requirements passed into law. Yesterday, Durbin and Kennedy secured an amendment in the Fiscal Year 2020 Commerce, Justice, and Science funding bill to provide DEA with additional tools to limit the over-production of prescription painkillers. 

After two decades of dramatic increases to the volume of opioids allowed to come to the market, the DEA has heeded Durbin and Kennedy’s repeated calls over the past several years to help prevent opioid addiction by responsibly reducing nearly all opioid quotas.  In part resulting from their efforts with DEA, five powerful, addictive painkillers are set to see a significant reduction in 2020 from what was allowed on the market just four years prior, including a 48 percent cut to oxycodone production over four years; a 59 percent cut to hydrocodone production over four years; and a 65 percent cut to fentanyl production over four years. 

Full text of today’s letter is available here and below:

November 1, 2019

Dear Acting Administrator Dhillon:

We write to comment on the proposed 2020 aggregate production quotas for controlled substances that the Drug Enforcement Administration (DEA) published on September 12.  As DEA finalizes the 2020 aggregate production quotas for schedule II opioids, we strongly urge the agency to consider the public health crisis caused by the opioid epidemic and meaningfully reduce opioids quotas from 2019 levels, as proposed in the Federal Register notice.

As our nation confronts the worst drug overdose epidemic in its history, we write to urge the Drug Enforcement Administration (DEA) to tackle the opioid crisis by utilizing new authorities that Congress provided to establish more sensible opioid production quotas for 2020.  The Opioid Quota Reform Act, which was signed into law as Section 3282 of the SUPPORT for Patients and Communities Act (P.L. 115-271), strengthened DEA’s statutory quota-setting authority by enhancing transparency and requiring opioid quotas to be adjusted to reflect diversion, overdose deaths, and public health.  As the bipartisan authors of that legislation, we strongly encourage you to use this new authority to rein in the pharmaceutical industry’s incessant demand for excessive levels of opioid production. 

We have previously shared our deep concern that, between 1993 and 2015, DEA allowed aggregate production quotas for oxycodone to increase 39-fold, hydrocodone to increase 12-fold, hydromorphone to increase 23-fold, and fentanyl to increase 25-fold.  Recent reporting from the Washington Post revealed that the pharmaceutical industry flooded every corner of the country with 76 billion oxycodone and hydrocodone pills between 2006 and 2012—outsized and unjustifiable volumes of painkiller production undertaken with DEA approval and awareness. 

The October 1 report from the Department of Justice’s Inspector General specifically highlighted that, while the opioid epidemic surged, “DEA was authorizing manufacturers to product substantially larger amounts of opioids.”  While we appreciate the initial steps taken in recent years to reduce the aggregate production quotas for schedule II opioids, we remain concerned that they are still far too high. 

Approximately thirteen billion opioid doses were put on the market in 2017—enough for every adult American to have at least a three-week prescription of painkillers.  As powerful painkillers are aggressively marketed and prescribed at high rates, this sheer volume of available opioids heightens the risk for illicit diversion and abuse.  For example, four in five new heroin users first began their addiction with prescription painkillers.

DEA explained in its proposed rule that its estimate of diversion—for the purpose of setting the aggregate production quotas—was based upon reported theft loss and seizures, and that DEA could not use Medicaid sales data or drug overdose and death data from the Centers for Disease Control and Prevention (CDC).  While we appreciate the challenges in directly linking patient overdoses to a specific controlled substance, DEA cannot ignore or discard this essential information from the quota-setting process.  DEA stated that, “illicit manufacturing cannot be tempered by adjusting the aggregate production quotas”, but this fails to acknowledge the potential impact that such adjustments may have on illicit demand. 

We fear that the explanation provided by DEA for ignoring the clear connection between the staggering volumes of painkillers approved for production and the current overdose epidemic signals that DEA is reverting to the short-sighted approach that precipitated this opioid crisis.  The statute is clear that DEA must exercise its quota authority to serve as a gatekeeper and weigh the public health impact of how many opioids it allows to be sold each year in the United States.     

As DEA finalizes the opioid production quotas for 2020, we urge you to apply DEA’s new authorities to prevent and limit opioid diversion due to excessively high production levels.  Thank you for your commitment to addressing the opioid epidemic.  We look forward to our continued engagement on this issue.

Sincerely,

According to this website https://www.reference.com/world-view/many-adults-live-usa-b830ecdfb6047660  there is abt 248 million adults in the USA..

Using the numbers in this article In 2016, the pharmaceutical industry put 14 billion opioid doses on the market—enough for every adult to have a one-month supply

Using those numbers means that each adult would get abt 60 doses of a opiate.

Using the normal number of chronic pain pts being 100 million… so it would suggests that abt 40% of the adults are chronic pain pts.

So if anyone wanted to do the math for 100 million chronic pain pts taking one opiate dose twice a day (60 doses/month) they would need 72 BILLION doses of opiates. Abt FIVE TIMES what Sen Durbin & Kennedy believes is an excessive amount of opiate production.

Within that 72 billion doses, does not provide any opiate doses for acute pain management… a hard to calculate number.

To put it another way… presuming that SIXTY DOSES/MONTH would provide adequate pain management for the 100 million chronic pain pts… ONLY ONE IN FIVE  (20%)  CHRONIC PAIN PTS would get adequate pain management.

Of course, there is no mention as to what mgs or what opiates they came up with this excessive opiate production.

It is also stated in the letter that in a SEVEN YEAR PERIOD  pharmaceutical industry flooded every corner of the country with 76 billion oxycodone and hydrocodone pills between 2006 and 2012. The pharmas produced enough oxycodone & Hydrocodone to potentially provide adequate pain management for chronic pain pts for a ONE YEAR PERIOD…again no provision for pts dealing with acute pain nor any considerations for high impact/intractable chronic pain pts nor pts that are fast/ultra fast metabolizers that need higher and/or more frequent doses.

Within the time frames that they claim there was excessive opiate production was during the “Decade of pain” that encourage prescribers to treat pain as the “5th vital sign” in a bill/law from the 106th Congress https://www.congress.gov/bill/106th-congress/house-bill/2260

This seems to follow a pattern with Congress… in 1914 they passed the Harrison Narcotic Act – which created the “black drug market” and then in 1970 they passed the Controlled Substance Act that declared a “war on drugs” that the 1914 act created… then in 2000 the “Decade of Pain” encourage prescribers to treat pain as the “5th vital sign”… now we are seeing Congress attempting to take corrective action from the outcomes of the 2000 law.

Maybe it is this sort of things that caused Einstein to create his infamous definition of “insanity” ?

Or is Congress like a dog chasing their tail, expending a lot of energy and revenue and getting no where ?

 

Texas commissioners: Mail order prescription is on average $29.09 more each Rx

Texas commissioners: Mail order prescription is more expensive

https://www.ncpanet.org/newsroom/qam/2019/12/17/texas-commissioners-mail-order-is-more-expensive

Commissioners in Collin County, Texas, had long incentivized their employees to use mail order, and even limited 90-day fills to mail order. After extensive analysis, they found that

most prescription drugs were more expensive under mail order, $29.09 more expensive per script.

That is before considering that the county paid for the third month’s fill and delivery fees. Commissioners recently changed their policy so county employees could get 90-day fills at retail and removed all incentives for employees to use mail order. County employees now have a choice. Here’s a video of the commissioners’ discussion on employee benefits for 2020 here

Fewer SUICIDES… more “deaths of despair” ?

There are fewer suicides related to opioids than previously believed, research says

https://www.cnn.com/2019/12/17/health/opioid-overdose-death-suicide-study/index.html

Since 1999, significant increases in US suicide rates have paralleled increases in drug overdoses from opioids. Experts have wondered how much the two might be intertwined, estimating that the

percent of suicides among opioid overdose deaths to be as high as 20% to 30%.

But a new analysis of numbers finds that the link between opioids and suicide might be much smaller than initially believed.
The percent of opioid-related suicides actually fell in recent years, dropping from 9% in 2000 to 4% in 2017, according to a research letter published Tuesday in the medical journal JAMA.
“It gives you a very different picture of the role of opioids in the suicide epidemic,” said Dr. Mark Olfson, lead author of the analysis and a professor of psychiatry at Columbia University Medical Center.
The conversation around “deaths of despair” — deaths related to suicide, drug overdose, liver disease and cirrhosis — has taken on a specific narrative, Olfson said, intertwining the opioid epidemic and suicide.

Deaths of despair

The phrase “deaths of despair” was coined by the Princeton-based economists Sir Angus Deaton and Anne Case. They were among the first to note these deaths have increased significantly in the United States since the 1990s, particularly among white males.

Increases in these “deaths of despair” have been so significant in recent years, that they are major drivers in reducing American life expectancy.

Deaton and Case noted that while the supply of opioids increased since 1999, it’s not the “fundamental factor” behind increased mortality, but rather, the prescription of opioids for chronic pain “added fuel to the flames” of overall mortality.
A report issued in September from the US Congress Joint Economic Committee titled “Long-Term Trends in Deaths of Despair” noted, “Mortality from deaths of despair far surpasses anything seen in America since the dawn of the 20th century. …The recent increase has primarily been driven by an unprecedented epidemic of drug overdoses.”

Opioids and suicide not as closely tied as believed

“There’s been a tendency as seeing opioid overdose and suicide as this one thing,” said Olfson, “but when you look at the deaths, they aren’t tied as strongly as we had imagined. “
Asking for help

The suicide rate in the United States has seen sharp increases in recent years. Studies have shown that the risk of suicide declines sharply when people call the national suicide hotline: 1-800-273-TALK.

There is also a crisis text line. For crisis support in Spanish, call 1-888-628-9454.

The lines are staffed by a mix of paid professionals and unpaid volunteers trained in crisis and suicide intervention. The confidential environment, the 24-hour accessibility, a caller’s ability to hang up at any time and the person-centered care have helped its success, advocates say.

Olfson and his colleagues analyzed mortality data from the National Vital Statistics System from 2000 to 2017, looking specifically at unintentional or accidental deaths, suicides and deaths of undetermined cause, and tallying those associated with opioids.

The proportion of opioid-related deaths related to suicide dropped from from 9% in 2000 to 4% in 2017. But, despite that decrease, researchers noted that between 2000 and 2017, the rate of opioid-related suicides actually increased in that same time frame. In 2000, there were 0.27 opioid-related suicides per 100,000 people. In 2017, that rate increased to 0.58 opioid-related suicides per 100,000 people.
Increases in opioid-related suicide rates were observed for males, females, all racial and ethnic groups, as well as all age groups — except for those between the ages of 35 and 44.

The emergence of fentanyl

Olfson believes the introduction of lethal and illicit fentanyl is a factor driving the drop in proportion of opioid-related suicides, even as the rate increased.
Fentanyl is a synthetic opioid that can be up to 50 times as potent as heroin. Overall fatal drug overdoses related to fentanyl skyrocketed more than 1,000% between 2011 and 2016. There were 70,237 fatal drug overdoses in 2017 and about 40% of them involved synthetic drugs such as fentanyl.
When looking at overall opioid-related deaths, the proportion of people accidentally dying from opioid overdose has increased significantly because of the power of fentanyl.
“It has it has contributed to a larger share of the deaths being accidental. So, in a way, it’s sort of crowding out the intentional deaths,” Olfson said.
Get CNN Health’s weekly newsletter
But Olfson was careful to note that this didn’t mean that researcher and health care providers shouldn’t be concerned about opioids and suicide.
“You can’t take your eye off of this — it just changes the view and our understanding,” he said.

DEA’S logic: how Rx opiates causes/linked to OD’s

DEA Obtusely Uses High School Wrestler‘s Death To Promote Anti-Drug Website

https://stockdailydish.com/dea-obtusely-uses-high-school-wrestlers-death-to-promote-anti-drug-website/

a high school wrestler who started taking Oxycodone as a senior. His doctor prescribed it to him after a shoulder injury that ended his wrestling career. At 21, he died from a fentanyl overdose. It is adviced for Yakima wrongful death lawyers for hire , if they need to fight for wrongful death or wrongful injury cases. 

That these two things are related is all but a foregone conclusion. In 2015, the same year Gintis died, 52,000 Americans died of an overdose. In two-thirds of those cases, the drugs were opioids. The connection between high school athletics and prescriptions to potential gateway drugs like Oxycodone or Ocycontin is understudied but increasingly .

Tessie Castillo, the advocacy and communications coordinator for the North Carolina Harm Reduction Coalition, believes Gintis was a victim of this connection. “What we see a lot, over and over again, is people getting injured and they go to the doctor and they’re prescribed pills and that’s the start of their addiction,” she told Yahoo. “It’s very connected to sports.”

Gintis’s mother, Marsha, seems to agree. She recently spoke at the North Carolina state legislature on behalf of the STOP act, targeting the over-prescription of pain killers. In recounting Gintis’s story she said, “Like so many others who now struggle with substance-abuse disorders, a prescription for opioids after suffering an athletic injury served as the catalyst for his downward spiral and ultimately his death.”Death cannot be compensated. However, the injury lawyers – The Rizzuto Law Firm can help you get anything you deserve if you or your loved ones suffered an injury.

In this context, it’s weird to see the DEA latching onto the story with this tweet:

The DEA is quote-tweeting its own affiliate account—one that pays lip service to drug prevention and does mention the wrestling injury—to unsuccessfully (their typo’d link leads to an unsecure site) promote It’s just a tweet, but it manages to be insensitive and ignorant at the same time. Blaming Gintis’s death on a one-time decision to take up drugs ignores the greater context of his tragedy, and oversimplifies a growing epidemic in ways that only make it harder to properly understand and deal with it.